Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ADVANCEPCS | 1,118,350 | reported | 17 Mar 2004 | tx 19+609,302−1,064,402 |
| Caris Life Sciences, Inc. | 118,621 | reported | 26 Feb 2026 | tx 4+1,268,621−5,000,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 26 Feb 2026 | GRANT_AWARD | Caris Life Sciences, Inc. | 2,492 | 20.06 USD | |
| 20 Jun 2025 | CONVERSION | Caris Life Sciences, Inc. | 1,250,000 | 0.00 USD | |
| 27 Feb 2025 | GRANT_AWARD | Caris Life Sciences, Inc. | 16,129 | 0.00 USD | |
| 20 Jun 2025 | CONVERSION | Caris Life Sciences, Inc. | 5,000,000 | — | deriv |
| 17 Mar 2004 | SALE | ADVANCEPCS | 55,100 | 70.70 USD | |
| 05 Mar 2004 | EXERCISE | ADVANCEPCS | 5,556 | 2.25 USD | |
| 05 Mar 2004 | EXERCISE | ADVANCEPCS | 130,458 | 7.34 USD | |
| 05 Mar 2004 | EXERCISE | ADVANCEPCS | 149,288 | 9.34 USD | |
| 05 Mar 2004 | EXERCISE | ADVANCEPCS | 100,000 | 10.00 USD | |
| 08 Mar 2004 | EXERCISE | ADVANCEPCS | 200,000 | 10.00 USD | |
| 08 Mar 2004 | EXERCISE | ADVANCEPCS | 24,000 | 28.65 USD | |
| 05 Mar 2004 | SALE | ADVANCEPCS | 5,556 | 71.82 USD | |
| 05 Mar 2004 | SALE | ADVANCEPCS | 130,458 | 72.03 USD | |
| 05 Mar 2004 | SALE | ADVANCEPCS | 24,436 | 71.75 USD | |
| 08 Mar 2004 | SALE | ADVANCEPCS | 124,852 | 72.12 USD | |
| 08 Mar 2004 | SALE | ADVANCEPCS | 64,698 | 72.17 USD | |
| 09 Mar 2004 | SALE | ADVANCEPCS | 50,000 | 72.72 USD | |
| 05 Mar 2004 | EXERCISE | ADVANCEPCS | 5,556 | 0.00 USD | deriv |
| 05 Mar 2004 | EXERCISE | ADVANCEPCS | 130,458 | 0.00 USD | deriv |
| 05 Mar 2004 | EXERCISE | ADVANCEPCS | 149,288 | 0.00 USD | deriv |
| 05 Mar 2004 | EXERCISE | ADVANCEPCS | 100,000 | 0.00 USD | deriv |
| 08 Mar 2004 | EXERCISE | ADVANCEPCS | 200,000 | 0.00 USD | deriv |
| 08 Mar 2004 | EXERCISE | ADVANCEPCS | 24,000 | 0.00 USD | deriv |